Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
neoplastic processes
MeSH D009385 - neoplastic processes
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D010335:
Pathologic processes
0 Companies
0 Drugs
Success rate
D009369:
Neoplasms
21 Companies
21 Drugs
$
Success rate
D009385:
Neoplastic processes
1 Company
1 Drug
$
Success rate
D000074723:
Oncogene addiction
0 Companies
0 Drugs
Success rate
D000708:
Anaplasia
0 Companies
0 Drugs
Success rate
D009361:
Neoplasm invasiveness
0 Companies
0 Drugs
Success rate
D009362:
Neoplasm metastasis
29 Companies
6 Drugs
$
Success rate
D009364:
Local neoplasm recurrence
0 Companies
0 Drugs
Success rate
D009365:
Spontaneous neoplasm regression
0 Companies
0 Drugs
Success rate
D018365:
Residual neoplasm
0 Companies
0 Drugs
Success rate
D063646:
Carcinogenesis
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
0
%
0/1
Phase 3
100
%
1/1
Approved:
1
Overall Success rate:
0%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use